Prostate oncology Clinical Trials in Boston, MA

As of June 2026, 56 paid clinical trials are recruiting for Prostate oncology in Boston, Massachusetts. Prostate oncology research evaluates next-generation hormone therapies, PARP inhibitors, radioligand treatments, and immune-based approaches for localized and advanced disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

56 clinical trials for Prostate oncology

·Clear filters·↓ Download CSV

Video Education With Result Dependent dIsclosure

for Genetic Testing

1 location in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT05225428·Recruiting

Apply to this trial

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

for Prostate Cancer

5 locations incl. Sacramento

Sponsor: University of British Columbia

Sex: Male·Age: 18+

Code: NCT04812366·Phase 2·Recruiting

Apply to this trial

Precision-Based Genomics in Prostate Cancer

for Prostate Cancer

11 locations incl. La Jolla

Sponsor: National Cancer Institute (NCI)

Sex: Male·Age: 18+

Code: NCT04706663·Recruiting

Apply to this trial

Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer

for Prostate Cancer

4 locations incl. Boston

Sponsor: Weill Medical College of Cornell University

Sex: Male·Age: 18+

Code: NCT04946370·Phase 1, Phase 2·Recruiting

Apply to this trial

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

for Prostate Cancer

20 locations incl. Long Beach

Sponsor: VA Office of Research and Development

Sex: Male·Age: 18+

Code: NCT04787744·Phase 2, Phase 3·Recruiting

Apply to this trial

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

for Advanced Solid Tumor

32 locations incl. Irvine

Sponsor: PMV Pharmaceuticals, Inc

Sex: All·Age: 12+

Code: NCT04585750·Phase 1, Phase 2·Recruiting

Apply to this trial

Jump: MR Simulation For Radiation Therapy Master Protocol

for Prostate Cancer

2 locations incl. Boston

Sponsor: Brigham and Women's Hospital

Sex: All·Age: 18+

Code: NCT04545957·Recruiting

Apply to this trial

Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer

for Prostate Cancer

1 location in Boston

Sponsor: Brigham and Women's Hospital

Sex: Male·Age: 22+

Code: NCT04399876·Phase 1·Enrolling By Invitation

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

for Prostate Carcinoma

8 locations incl. Duarte

Sponsor: University of Washington

Sex: Male·Age: 40+·Accepts healthy volunteers

Code: NCT04472338·Recruiting

Apply to this trial

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

for Prostate Adenocarcinoma

Drug: Apalutamide

345 locations incl. Phoenix

Sponsor: NRG Oncology

Sex: Male·Age: 18+

Code: NCT04134260·Phase 3·Recruiting

Apply to this trial

Prostate Cancer Genetic Risk Evaluation and Screening Study

for Prostatic Neoplasm

1 location in Boston

Sponsor: Massachusetts General Hospital

Sex: Male·Age: 35 - 74

Code: NCT05129605·Recruiting

Apply to this trial

Serial MRI Scans During Radiation Therapy

for Glioblastoma

2 locations incl. Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT04188535·Recruiting

Apply to this trial

Stereotactic Magnetic Resonance Guided Radiation Therapy

for Pancreas Cancer

2 locations incl. Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT04115254·Recruiting

Apply to this trial

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

for Advanced Solid Tumor

Drug: Tulmimetostat

17 locations incl. Atlanta

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT04104776·Phase 1, Phase 2·Recruiting

Apply to this trial

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

for Prostate Cancer

48 locations incl. Birmingham

Sponsor: Prostate Cancer Clinical Trials Consortium

Sex: Male·Age: 21+

Code: NCT03151629·Recruiting

Apply to this trial

Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy

for Prostate Cancer

1 location in Boston

Sponsor: Massachusetts General Hospital

Sex: Male·Age: 18+

Code: NCT01961713·Recruiting

Apply to this trial

Conditions in Prostate oncology (Boston, MA)

Prostate cancer· 48 Metastatic prostate cancer· 13